Literature DB >> 20044848

The AMCP format for formulary submissions version 3.0.

.   

Abstract

Mesh：

Year:  2010        PMID： 20044848     DOI： 10.18553/jmcp.2010.16.S6-A.1

Source DB:  PubMed          Journal:  J Manag Care Pharm        ISSN： 1083-4087


× No keyword cloud information.
  8 in total

1.  Improving confidence in observational studies : should statistical analysis plans be made publicly available?

Authors:  Eberechukwu Onukwugha
Journal:  Pharmacoeconomics       Date:  2013-03       Impact factor: 4.981

Review 2.  Asthma outcomes: healthcare utilization and costs.

Authors:  Lara J Akinbami; Sean D Sullivan; Jonathan D Campbell; Robert W Grundmeier; Tina V Hartert; Todd A Lee; Robert A Smith
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

3.  Guideline for postmarketing Chinese medicine pharmacoeconomic evaluation.

Authors:  Xin Wang; Zhi-Fei Wang; Yan-Ming Xie; Wen Zhang; Xing Liao; Yan-Peng Chang
Journal:  Chin J Integr Med       Date:  2014-03-27       Impact factor: 1.978

4.  Do changes in drug coverage policy point to an increased role for cost-effectiveness analysis in the USA?

Authors:  James D Chambers
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

5.  An Elective Course for Student Pharmacists on Pharmaceutical Industry Practice.

Authors:  Bobby Jacob; Samuel K Peasah
Journal:  Am J Pharm Educ       Date:  2019-10       Impact factor: 2.047

6.  Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease.

Authors:  Usha G Mallya; Susan H Boklage; Andrew Koren; Thomas E Delea; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2018-01       Impact factor: 4.981

7.  Evaluating the Cost-Effectiveness of Proportional-Assist Ventilation Plus vs. Pressure Support Ventilation in the Intensive Care Unit in Two Countries.

Authors:  Rhodri Saunders; Dimitris Geogopoulos
Journal:  Front Public Health       Date:  2018-06-06

8.  Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years.

Authors:  Andreas Karabis; Michelle Mocarski; Indra Eijgelshoven; Gert Bergman
Journal:  Clinicoecon Outcomes Res       Date:  2014-04-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.